Melatonin Protects Mitochondria and ATP Production During SARS-CoV-2 Acute Infection and Post-Infection

Doris Loh
28 min readAug 5, 2022

Background

Melatonin (N-acetyl-5-methoxytryptamine) is a ubiquitous, mitochondria-targeted molecule present in all tested eukarya and bacteria. In March 2022, the first discovery of the serotonin N-acetyltransferase (SNAT) gene — responsible for the penultimate formation of N-acetylserotonin (NAS) before its final conversion into melatonin — in archaea further consolidates the status of melatonin as a regulator of biomolecular condensates in all three domains of life in the cellular empire. RNA viruses including SARS-CoV-2 contain proteins with intrinsically disordered regions that undergo liquid-liquid phase separation (LLPS). LLPS of these proteins form membraneless condensates that act as “viral factories” to facilitate and enhance replication. Phase separation of the SARS-CoV-2 nucleocapsid (N) protein is associated with mitochondrial dysfunction and rewiring of energy production away from oxidative phosphorylation (OXPHOS) to favor aerobic glycolysis in cytoplasm. Increased ATP in cytoplasm supports viral replication. Melatonin protects mitochondria from damage, maintains adequate ATP levels to disassemble “viral factories”, and prevents suppression of host antiviral immune responses by inhibiting nucleocapsid phase separation via antioxidant-dependent and…

--

--

Doris Loh
Doris Loh

Written by Doris Loh

Doris Loh is an independent researcher/writer investigating familiar and innovative health topics using unique perspectives in traditional and quantum biology.